Ticker Details
Acrivon Therapeutics, Inc.
IPO Date:	November 15, 2022
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$48.28M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.28 | 4.02%
Avg Daily Range (30 D):	$0.06 | 3.36%
Avg Daily Range (90 D):	$0.09 | 4.24%

Institutional Daily Volume
Avg Daily Volume:	.38M
Avg Daily Volume (30 D):	1.07M
Avg Daily Volume (90 D):	1.29M

Trade Size
Avg Trade Size (Sh.):	161
Avg Trade Size (Sh.) (30 D):	271
Avg Trade Size (Sh.) (90 D):	191

Institutional Trades
Total Institutional Trades:	21
Avg Institutional Trade:	$2.21M
Avg Institutional Trade (30 D):	$.56M
Avg Institutional Trade (90 D):	$.56M
Avg Institutional Trade Volume:	.23M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$3.11M
Avg Closing Trade (30 D):	$1.11M
Avg Closing Trade (90 D):	$1.11M
Avg Closing Volume:	320.84K

News

Jul 15, 2025 @ 5:00 PM Endometrial Cancer Clinical Trial Pipeline Insight... Source: Delveinsight

Sep 14, 2024 @ 7:10 AM Acrivon Therapeutics Reports Positive Endometrial ... Source: N/A

Jul 10, 2024 @ 1:01 PM Athira (ATHA) Completes Dosing in Alzheimer's Stud... Source: N/A

Jul 5, 2024 @ 1:31 PM AstraZeneca's (AZN) Tagrisso Gets EU Nod for First... Source: N/A

Jul 2, 2024 @ 4:12 PM SpringWorks (SWTX) Completes NDA Submission for Mi... Source: Zacks Equity Research

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-2.12	$-.47
Diluted EPS	$-2.12	$-.47
Revenue	$M	$M
Gross Profit
Net Income / Loss	$-81.75M	$-18.23M	$-21.01M
Operating Income / Loss	$-88.95M	$-19.69M
Cost of Revenue
Net Cash Flow	$-8M
PE Ratio